相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Pragmatic and open science-based solution to a current problem in the reporting of living systematic reviews
Maria-Inti Metzendorf et al.
BMJ EVIDENCE-BASED MEDICINE (2023)
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: a meta-analysis
Wen Wen et al.
ANNALS OF MEDICINE (2022)
In the age of Omicron variant: Paxlovid raises new hopes of COVID-19 recovery
Zhonglei Wang et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
Emi Takashita et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Jennifer Hammond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
R. L. Gottlieb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina
Dan-Yu Lin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance
Shi-Yan Ren et al.
WORLD JOURNAL OF CLINICAL CASES (2022)
Cautious Optimism and Considerations for Health Providers and Patients: Oral Antiviral for Early Treatment of High-Risk Patients and Vaccines for Prevention of COVID-19
Jennifer Caceres et al.
AMERICAN JOURNAL OF MEDICINE (2022)
Ivermectin for preventing and treating COVID-19
Maria Popp et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2022)
Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
Sk. Abdul Amin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Willingness, beliefs, and barriers regarding the COVID-19 vaccine in Saudi Arabia: a multiregional cross-sectional study
Noura Altulahi et al.
BMC FAMILY PRACTICE (2021)
Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication
Yi Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2021)
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)
Chaolin Huang et al.
LANCET (2021)
Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis
Adam Booth et al.
PLOS ONE (2021)
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
Dafydd R. Owen et al.
SCIENCE (2021)
Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One
Philippine Eloy et al.
EBIOMEDICINE (2021)
Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study
Chao Wang et al.
VACCINE (2021)
Hospitalisation among vaccine breakthrough COVID-19 infections
Prerak Juthani et al.
LANCET INFECTIOUS DISEASES (2021)
SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Antibiotics for the treatment of COVID-19
Maria Popp et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Ivermectin for preventing and treating COVID-19
Maria Popp et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Check for publication integrity before misconduct
Andrew Grey et al.
NATURE (2020)
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
Lisi Deng et al.
JOURNAL OF INFECTION (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
Christopher M. Petrilli et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
Christian Karagiannidis et al.
LANCET RESPIRATORY MEDICINE (2020)
Characteristics Associated with Hospitalization Among Patients with COVID-19-Metropolitan Atlanta, Georgia, March-April 2020
Marie E. Killerby et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
Giovanni Salvatori et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Viral dynamics in mild and severe cases of COVID-19
Yang Liu et al.
LANCET INFECTIOUS DISEASES (2020)
A minimal common outcome measure set for COVID-19 clinical research
J. C. Marshall et al.
LANCET INFECTIOUS DISEASES (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries
Michael C. Grant et al.
PLOS ONE (2020)
The carnage of substandard research during the COVID-19 pandemic: a call for quality
Katrina A. Bramstedt
JOURNAL OF MEDICAL ETHICS (2020)
Pathophysiology and treatment strategies for COVID-19
Manoj Kumar et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
A living WHO guideline on drugs for covid-19
Francois Lamontagne et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein (vol 180, 281.e1, 2020)
Alexandra C. Walls et al.
CELL (2020)
Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients
Hitoshi Kawasuji et al.
PLOS ONE (2020)
SARS-CoV-2 viral load is associated with increased disease severity and mortality
Jesse Fajnzylber et al.
NATURE COMMUNICATIONS (2020)
Health equity and COVID-19: global perspectives
Efrat Shadmi et al.
INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2020)
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection (Review)
Jacqueline Dinnes et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Plea for routinely presenting prediction intervals in meta-analysis
Joanna IntHout et al.
BMJ OPEN (2016)
PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity
Vivian Welch et al.
PLOS MEDICINE (2012)
GRADE guidelines: 3. Rating the quality of evidence
Howard Balshem et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode
Shuai Chen et al.
PROTEIN & CELL (2010)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)